{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:04:54Z","timestamp":1790006694288,"version":"4.0.1"},"reference-count":31,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Persistent misinformation and low confidence impede human papillomavirus (HPV) vaccine uptake in Japan. Artificial intelligence (AI)\u2013driven conversational agents may provide scalable vaccine education, but randomized evidence for HPV vaccine communication remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine whether an AI-driven HPV vaccine chatbot improves caregiver HPV vaccine literacy compared with a government leaflet.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>Parallel-group randomized clinical trial (RCT) conducted through a national research panel of female caregivers in Japan with unvaccinated daughters aged 12 to 18 years from November 30 to December 27, 2024, with 2-week follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Participants were randomized 1:1 to an AI-driven HPV vaccine chatbot or standard government HPV vaccine leaflet.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcomes and measures<\/jats:title>\n                    <jats:p>The primary outcome was an HPV vaccine literacy, evaluated immediately after intervention to estimate immediate intervention efficacy and evaluated at 2-week follow-up to estimate durability. HPV vaccine literacy was measured using 7 factual questions about HPV and HPV vaccination; scores are shown on a 0 to 7 scale, with higher scores indicating more correct responses.The secondary outcome was decision to vaccinate at 2-week follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 848 randomized participants, 704 of 841 (83.7%) were included in the immediate modified intention-to-treat (mITT) analysis (353 chatbot, 351 leaflet) and 477 of 841 (56.7%) in the mITT analysis at 2 weeks (237 chatbot, 240 leaflet). A total of 447 of 703 participants (63.6%) were aged 40 to 49 years and had college or university education (472 of 703 participants [67.1%]). Immediately after the intervention, analysis of covariance-adjusted literacy was higher with the chatbot (adjusted mean difference, 0.30 points on the 0 to 7 scale; 95% CI, 0.18-0.43 points;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). At the 2-week durability assessment, mean (SD) literacy increased by 0.40 (1.21) with the chatbot vs 0.28 (1.13) points with the leaflet; adjusted literacy again favored the chatbot (adjusted mean difference, 0.30 points; 95% CI, 0.13-0.47;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). At 2 weeks, caregivers\u2019 vaccination decisions did not differ between groups (102 of 253 participants [40.3%] vs 103 of 260 participants [39.6%]; adjusted odds ratio, 0.74; 95% CI, 0.41 to 1.33;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.31).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this RCT of female caregivers in Japan, an AI-driven HPV vaccine chatbot produced higher adjusted HPV vaccine literacy than a government leaflet immediately after intervention and at 2-week follow-up, without a measurable short-term effect on vaccination decision. Conversational AI may complement official materials and health care professional recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT06702423\">NCT06702423<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.34696","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:30:47Z","timestamp":1790004647000},"page":"e2634696","source":"Crossref","is-referenced-by-count":0,"title":["AI Chatbot Use for Human Papillomavirus Vaccine Literacy in Japan"],"prefix":"10.1001","volume":"9","author":[{"given":"Kana","family":"Kobayashi","sequence":"first","affiliation":[{"name":"Department of Infectious Disease Epidemiology and Dynamics, London School of Hygiene and Tropical Medicine Faculty of Epidemiology and Public Health, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengdong","family":"Wu","sequence":"additional","affiliation":[{"name":"Moonrise Initiative, Hong Kong Special Administrative Region, Hong Kong, China"},{"name":"Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Special Administrative Region, Hong Kong, China"},{"name":"WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Tomoi","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology and Dynamics, London School of Hygiene and Tropical Medicine Faculty of Epidemiology and Public Health, London, United Kingdom"},{"name":"Department of Global Health, Nagasaki University School of Tropical Medicine and Global Health, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Global Health, Nagasaki University School of Tropical Medicine and Global Health, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi J.","family":"Larson","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology and Dynamics, London School of Hygiene and Tropical Medicine Faculty of Epidemiology and Public Health, London, United Kingdom"},{"name":"Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Leung","sequence":"additional","affiliation":[{"name":"Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Special Administrative Region, Hong Kong, China"},{"name":"WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong, China"},{"name":"The Hong Kong Jockey Club Global Health Institute, Hong Kong Special Administrative Region, Hong Kong, China"},{"name":"The University of Hong Kong\u2014Shenzhen Hospital, Shenzhen, China"},{"name":"Division of Emerging Interdisciplinary Areas, The Hong Kong University of Science and Technology, Hong Kong Special Administrative Region, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph T.","family":"Wu","sequence":"additional","affiliation":[{"name":"Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Special Administrative Region, Hong Kong, China"},{"name":"WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong, China"},{"name":"The Hong Kong Jockey Club Global Health Institute, Hong Kong Special Administrative Region, Hong Kong, China"},{"name":"The University of Hong Kong\u2014Shenzhen Hospital, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leesa","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology and Dynamics, London School of Hygiene and Tropical Medicine Faculty of Epidemiology and Public Health, London, United Kingdom"},{"name":"Moonrise Initiative, Hong Kong Special Administrative Region, Hong Kong, China"},{"name":"Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Special Administrative Region, Hong Kong, China"},{"name":"WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"issue":"10197","key":"zoi260936r3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"zoi260936r4","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/S2468-2667(18)30183-X","article-title":"The projected timeframe until cervical cancer elimination in Australia: a modelling study.","volume":"4","author":"Hall","year":"2019","journal-title":"Lancet Public Health"},{"issue":"10316","key":"zoi260936r5","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","article-title":"The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study.","volume":"398","author":"Falcaro","year":"2021","journal-title":"Lancet"},{"issue":"7-8","key":"zoi260936r6","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1080\/21645515.2018.1564436","article-title":"HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe.","volume":"15","author":"Karafillakis","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"zoi260936r7","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.4161\/21645515.2014.969618","article-title":"Tracking the global spread of vaccine sentiments: the global response to Japan\u2019s suspension of its HPV vaccine recommendation.","volume":"10","author":"Larson","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"9987","key":"zoi260936r9","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1016\/S0140-6736(15)61152-7","article-title":"HPV vaccination crisis in Japan.","volume":"385","author":"Hanley","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"zoi260936r10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21645515.2021.1986333","article-title":"Changing trends in HPV vaccination in Japan.","volume":"18","author":"Ujiie","year":"2022","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"zoi260936r12","doi-asserted-by":"publisher","first-page":"e223","DOI":"10.1016\/S2468-2667(20)30010-4","article-title":"Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study.","volume":"5","author":"Simms","year":"2020","journal-title":"Lancet Public Health"},{"issue":"48","key":"zoi260936r14","doi-asserted-by":"publisher","first-page":"7147","DOI":"10.1016\/j.vaccine.2023.10.024","article-title":"Age, gender and socioeconomic disparities in human papillomavirus (HPV) awareness and knowledge among Japanese adults after a 7-year suspension of proactive recommendation for the HPV vaccine: a nationally representative cross-sectional survey.","volume":"41","author":"Terada","year":"2023","journal-title":"Vaccine"},{"issue":"24","key":"zoi260936r15","doi-asserted-by":"publisher","DOI":"10.3390\/app112412142","article-title":"Development and evaluation of a child vaccination chatbot real-time consultation messenger service during the COVID-19 pandemic.","volume":"11","author":"Hong","year":"2021","journal-title":"Appl Sci (Basel)"},{"key":"zoi260936r16","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126559","article-title":"Exploring Chatbot contributions to enhancing vaccine literacy and uptake: a scoping review of the literature.","volume":"44","author":"Cosma","year":"2025","journal-title":"Vaccine"},{"issue":"12","key":"zoi260936r18","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1111\/jog.12822","article-title":"Survey of Japanese mothers of daughters eligible for human papillomavirus vaccination on attitudes about media reports of adverse events and the suspension of governmental recommendation for vaccination.","volume":"41","author":"Egawa-Takata","year":"2015","journal-title":"J Obstet Gynaecol Res"},{"issue":"9609","key":"zoi260936r19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0140-6736(07)61835-2","article-title":"CONSORT for reporting randomised trials in journal and conference abstracts.","volume":"371","author":"Hopewell","year":"2008","journal-title":"Lancet"},{"issue":"5","key":"zoi260936r22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2022-010370","article-title":"Effect of a mobile app chatbot and an interactive small-group webinar on COVID-19 vaccine intention and confidence in Japan: a randomised controlled trial.","volume":"8","author":"Kobayashi","year":"2023","journal-title":"BMJ Glob Health"},{"issue":"9","key":"zoi260936r24","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1080\/21645515.2021.1918042","article-title":"Understanding confidence in the human papillomavirus vaccine in Japan: a web-based survey of mothers, female adolescents, and healthcare professionals.","volume":"17","author":"Shuto","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"zoi260936r25","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1038\/s41591-025-03618-6","article-title":"A vaccine chatbot intervention for parents to improve HPV vaccination uptake among middle school girls: a cluster randomized trial.","volume":"31","author":"Hou","year":"2025","journal-title":"Nat Med"},{"issue":"9","key":"zoi260936r26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.46234\/ccdcw2023.036","article-title":"Knowledge of cervical cancer and HPV, and willingness to receive HPV vaccination among 20-45-year-old women\u2014six provinces, China, 2018.","volume":"5","author":"Gao","year":"2023","journal-title":"China CDC Wkly"},{"issue":"3","key":"zoi260936r27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1177\/1529100618760521","article-title":"Increasing vaccination: putting psychological science into action.","volume":"18","author":"Brewer","year":"2017","journal-title":"Psychol Sci Public Interest"},{"issue":"11","key":"zoi260936r28","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.3390\/vaccines9111263","article-title":"Cervical cancer protection in Japan: where are we?","volume":"9","author":"Yagi","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"9","key":"zoi260936r29","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1080\/21645515.2021.1910001","article-title":"A potential means to help the HPV vaccine penetrate the Japanese public while under the continued suspension of governmental recommendation.","volume":"17","author":"Ugumori","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"zoi260936r30","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/bdm.3960030404","article-title":"Reluctance to vaccinate: omission bias and ambiguity.","volume":"3","author":"Ritov","year":"1990","journal-title":"J Behav Decis Making"},{"key":"zoi260936r23","volume-title":"Release 18","author":"Stata Statistical Software","year":"2023"},{"key":"zoi260936r1","unstructured":"National Cancer Center Cancer Information Service. Cancer statistics (National Cancer Registry, Ministry of Health, Labour and Welfare). 2021. Accessed May 26, 2025. https:\/\/ganjoho.jp\/reg_stat\/statistics\/data\/dl\/index.html#a14"},{"key":"zoi260936r2","unstructured":"National Cancer Center Cancer Information Service. Cancer statistics (Vital Statistics of Japan, Ministry of Health, Labour and Welfare). 2023. Accessed May 26, 2025. https:\/\/ganjoho.jp\/reg_stat\/statistics\/data\/dl\/index.html#a14"},{"key":"zoi260936r8","unstructured":"Ministry of Health. Labour and Welfare. Recommendation on handling routine immunization for human papillomavirus infection. 2013. Accessed August 12, 2026. https:\/\/www.mhlw.go.jp\/bunya\/kenkou\/kekkaku-kansenshou28\/pdf\/kankoku_h25_6_01.pdf."},{"key":"zoi260936r11","unstructured":"Ministry of Health. Labour and Welfare. Number of persons receiving routine immunizations. 2022. Accessed August 12, 2026. https:\/\/www.mhlw.go.jp\/topics\/bcg\/other\/5.html."},{"key":"zoi260936r13","unstructured":"Ministry of Health. Labour and Welfare. Future action on routine immunization related to human papillomavirus infection. 2021. Accessed August 12, 2026. https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/kenkou\/kekkaku-kansenshou19\/notifications.html."},{"key":"zoi260936r17","unstructured":"World Health Organization. Understanding the behavioural and social drivers of vaccine uptake WHO position paper. 2022. Accessed August 12, 2026. https:\/\/www.who.int\/publications\/i\/item\/who-wer9720-209-224"},{"key":"zoi260936r20","unstructured":"Opinion Research Business International. Data Collection. Accessed August 12, 2026. https:\/\/orb-international.com\/data-collection\/."},{"key":"zoi260936r21","unstructured":"Ministry of Health. Labour and Welfare. Please learn about the HPV vaccine. 2025. Accessed August 12, 2026. https:\/\/www.mhlw.go.jp\/content\/001682787.pdf."},{"key":"zoi260936r31","unstructured":"Lewandowsky? S, Cook? J, Ecker? UKH, . The debunking handbook 2020, 2020. Accessed August 12, 2026. https:\/\/climatecommunication.gmu.edu\/all\/the-debunking-handbook-2020\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2854271\/kobayashi_2026_oi_260936_1789154684.01339.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:30:52Z","timestamp":1790004652000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2854271"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.34696","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]}}}